Gyre Therapeutics GYRE
NASDAQ GYRE
$5.86 -0.04 (-0.68%)
At close: Oct 22, 2026 · 4:00 PM EDT

Gyre Therapeutics (GYRE) Long-Term Debt Issuances (2010 - 2015)

Updated

Gyre Therapeutics' Long-Term Debt Issuances came in at $1.89 million for FY2015.

Analysis

Gyre Therapeutics (GYRE) Long-Term Debt Issuances (2010 - 2015) Analysis & Trends

  • Long-Term Debt Issuances carries a five-year compound annual growth rate of 9.0% (FY2010 to FY2015).
  • The FY2015 figure represents the highest annual Long-Term Debt Issuances since FY2011.
  • Per Business Quant, earlier years put Long-Term Debt Issuances at $2.13 million in FY2011 (+73.6%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,142.35 Bn 1,110.94 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 635.52 Bn 555.38 Bn 17.30 Bn -
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn -
4 Merck 356.35 Bn 310.72 Bn 12.21 Bn -
5 Novartis Ag 300.53 Bn 264.52 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 263.02 Bn 236.71 Bn 12.86 Bn -
7 Amgen 238.00 Bn 193.40 Bn 7.24 Bn -
8 Gilead Sciences 194.35 Bn 168.55 Bn 6.22 Bn -
9 Pfizer 170.37 Bn 117.02 Bn 10.94 Bn -
10 Gyre Therapeutics 575.65 Mn 343.80 Mn 26.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 -5,000.00
Sep 30, 2010 1.23 Mn
API Access

Gyre Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=GYRE&period=max&api_key=YOUR_API_KEY